Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Dias, Flávia Regina Cruz, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, Robert J. Carey, and Marinete Pinheiro Carrera. "Residual dopamine receptor desensitization following either high-or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine." Psychopharmacology 225, no. 1 (2013): 141-150.

de Lange, Elizabeth CM. "Pharmacometrics in psychiatric diseases." In Applied Pharmacometrics, pp. 407-449. Springer, New York, NY, 2014.

Robinson, Sarah B., Osama Refai, J. Andrew Hardaway, Sarah Sturgeon, Tessa Popay, Daniel P. Bermingham, Phyllis Freeman, Jane Wright, and Randy D. Blakely. "Dopamine-dependent, swimming-induced paralysis arises as a consequence of loss of function mutations in the RUNX transcription factor RNT-1." PloS one 14, no. 5 (2019): e0216417.

Cardosa, Daniel, Joseph Wakeham, Philippa Amy Shaw, Brittany Dutton, and Levine Wildman. "Chlorpromazine versus thiothixene for people with schizophrenia (Protocol)." Cochrane Database of Systematic Reviews 9 (2017).

Li, Zongchang, Ying He, Hongying Han, Yao Zhou, Xiaoqian Ma, Dong Wang, Jun Zhou et al. "COMT, 5-HTR2A, and SLC6A4 mRNA expressions in first-episode antipsychotic-naive schizophrenia and association with treatment outcomes." Frontiers in psychiatry 9 (2018): 577.

Gründer, Gerhard, Philipp Bauknecht, Stefan Klingberg, Karolina Leopold, Michael Paulzen, Stefanie Schell, Katarina Stengler, and Stefan Leucht. "Treatment goals for patients with schizophrenia—a narrative review of physician and patient perspectives." Pharmacopsychiatry (2020).

Schultze-Lutter, Frauke, and Benno G. Schimmelmann. "Psychotische Störungen im DSM-5: DSM-5 Kommentar." Zeitschrift für Kinder-und Jugendpsychiatrie und Psychotherapie 42, no. 3 (2014): 193-202.

White, William Allen. "Antipsychotic agents." Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness (2012): 31.

Grover, Sandeep, Swapnajeet Sahoo, and Aseem Mehra. "Perceptions of psychiatrists toward the use of long-acting injectable antipsychotics: an online survey study from India." Journal of clinical psychopharmacology 39, no. 6 (2019): 611-619.

Alonso-Vega, Jesús, Miguel Núñez de Prado-Gordillo, Gladis Lee Pereira, and María Xesús Froján-Parga. "El tratamiento de Enfermedades Mentales Graves desde la investigación de procesos." (2019): 44-65.

Blom, Jan Dirk, Bastiaan C. Ter Meulen, and Jitze Dool. "A century of prosopometamorphopsia studies." Cortex (2021).

Bailliard, Antoine L., and Stephanie C. Whigham. "Linking neuroscience, function, and intervention: A scoping review of sensory processing and mental illness." American Journal of Occupational Therapy 71, no. 5 (2017): 7105100040p1-7105100040p18.

Altamura, A. Carlo. "From'classical'antipsychotics to'multidimensional stabilizers': do we need a new classification for novel drugs used in schizophrenia?." Neuropsychiatry 1, no. 6 (2011): 541.

Rakovska, Angelina, Daniel Javitt, Polina Petkova-Kirova, Andrea Balla, Rosalind Ang, and Reni Kalfin. "Neurochemical evidence that cysteamine modulates amphetamine-induced dopaminergic neuronal activity in striatum by decreasing dopamine release: an in vivo microdialysis study in freely moving rats." Brain research bulletin 153 (2019): 39-46.

Okbay, Aysu. Essays on Genetics and the Social Sciences. No. EPS-2017-413-S&E. 2017.

Svane, Kirsten C., Ericka-Kate Asis, Anton Omelchenko, Ansley J. Kunnath, Linda M. Brzustowicz, Steven M. Silverstein, and Bonnie L. Firestein. "D-Serine administration affects nitric oxide synthase 1 adaptor protein and DISC1 expression in sex-specific manner." Molecular and Cellular Neuroscience 89 (2018): 20-32.

Gatch, Michael B., Ritu A. Shetty, Nathalie Sumien, and Michael J. Forster. "Behavioral effects of four novel synthetic cathinone analogs in rodents." Addiction Biology 26, no. 4 (2021): e12987.

van Rooy, Inge, Shin-Ying Wu, Gert Storm, Wim E. Hennink, Heike Dinter-Heidorn, Raymond M. Schiffelers, and Enrico Mastrobattista. "Preparation and characterization of liposomal formulations of neurotensin-degrading enzyme inhibitors." International journal of pharmaceutics 416, no. 2 (2011): 448-452.

Zamengo, Luca, Giampietro Frison, and Guus Zwitser. "Understanding and managing the new psychoactive substances phenomenon: a holistic approach." Journal of public health policy 40, no. 2 (2019): 217-235.

Wang, Lien, Yan Zhang, Chaoran Wang, Xiuli Zhang, Zhiwei Wang, Xinmiao Liang, Amal Alachkar, and Olivier Civelli. "A Natural Product with High Affinity to Sigma and 5-HT 7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia." Neurochemical research 44, no. 11 (2019): 2536-2545.